Media Coverage

Media articles featuring INFORMS members in the news.

Most Recent Media Coverage

Topic
How Will You Be Told When It's Your Turn for a COVID-19 Vaccine? It's Complicated

How Will You Be Told When It's Your Turn for a COVID-19 Vaccine? It's Complicated

USA Today, December 24, 2020

Will you get a text from your doctor? Will you read about it online? Or will you have to check the Centers for Disease Control and Prevention website to know when it's your turn in line? As COVID-19 vaccines roll out to limited groups of people across the United States, how people learn they are eligible to get their shots won't be as clear while supplies remain limited, according to public health and policy experts and state vaccination plans. "I think it's going to be a little bit murky," said Katie Greene, a visiting policy associate at the Duke-Margolis Center for Health Policy.

The Oxford-AstraZeneca Vaccine Could be a Game-Changer for Inequality

The Oxford-AstraZeneca Vaccine Could be a Game-Changer for Inequality

Barron's, December 31, 2020

Mass vaccination offers hope for a return to the prepandemic normal. But the distribution process also comes with some potentially nasty side effects: Vaccination without a careful plan could inadvertently make the world even more unequal than a year ago. The two initial vaccine candidates, from Pfizer-BioNTech and Moderna, may have particularly problematic consequences for inequality. But the candidate that may have seemed like a runner-up in the vaccine race, from Oxford- AstraZeneca, has strong potential to finish as the most essential vaccine to end the pandemic.

Opinion: Looking Toward a Post-Vaccine COVID-19 America

Opinion: Looking Toward a Post-Vaccine COVID-19 America

The Detroit News, December 27, 2020

Immunization of health-care workers and residents of long-term care facilities has begun.  With each day bringing over 250,000 new confirmed cases and well over 2,000 additional deaths in the U.S., help is on the way to curb the COVID-19 momentum plaguing our nation. The full benefits of the vaccine will not be realized until tens of millions of people receive their two-dose regimen, which will likely not occur until the summer of 2021.  

Collaboration, Not Competition, Will Lead to More COVID-19 Vaccine Options

Collaboration, Not Competition, Will Lead to More COVID-19 Vaccine Options

The Washington Times, December 24, 2020

The U.S. Food and Drug Administration (FDA) has approved two COVID-19 vaccines under the Emergency Use Authorization (EUA) process. With these approvals, the immunization of health care workers and those in long-term care facilities has begun, providing them with a measure of protection against COVID-19. Waiting in the immunization queue are essential workers and at-risk populations. The expectation is that vaccines will be available for all who wish to be immunized by the middle of 2021.

Are You Eligible for a COVID-19 Vaccine? Washington State to Launch Tool, Rely on Honor System

Are You Eligible for a COVID-19 Vaccine? Washington State to Launch Tool, Rely on Honor System

The Seattle Times, December 31, 2020

Washington state will rely on an honor system to determine eligibility for COVID-19 vaccinations, so those administering vaccines do not have to police who qualifies. The state plans to launch an online questionnaire — called PhaseFinder — soon where people can determine their own eligibility for vaccination. When more vaccination sites are available, members of the public could present screenshots of their questionnaire results at vaccination sites, said Mary Huynh, a deputy director at the state Department of Health. The state also plans to provide a template letter for employers to vouch for workers’ eligibility.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Artificial Intelligence

Why 23andMe’s Genetic Data Could Be a ‘Gold Mine’ for AI Companies

Why 23andMe’s Genetic Data Could Be a ‘Gold Mine’ for AI Companies

TIME, March 26, 2025

The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night after years of financial struggles. This means that all of the extremely personal user data could be up for sale—and that vast trove of genetic data could draw interest from AI companies looking to train their data sets, experts say.

Healthcare

Want to reduce the cost of healthcare? Start with our billing practices.

Want to reduce the cost of healthcare? Start with our billing practices.

The Hill, March 11, 2025

Robert F. Kennedy Jr., as the new secretary of Health and Human Services, is the nation’s de facto healthcare czar. He will have influence over numerous highly visible agencies, including the Centers for Disease Control and Prevention, the National Institutes of Health and the Food and Drug Administration, among others. Given that healthcare is something that touches everyone’s life, his footprint of influence will be expansive. 

We all benefit from and are hurt by health insurance claim denials

We all benefit from and are hurt by health insurance claim denials

Atlanta Journal Constitution, January 23, 2025

Health insurance has become necessary, with large and unpredictable health care costs always looming before each of us. Unfortunately, the majority of people have experienced problems when using their health insurance to pay for their medical care. Health insurance serves as the buffer between patients and the medical care system, using population pooling to mitigate the risk exposure on any one individual.

Supply Chain

Experts warn logistics industry stakeholders to make contingency plans

Experts warn logistics industry stakeholders to make contingency plans

Seafood Source, March 10, 2025

In their March 2025 forecasts, shipping and logistics experts are warning those who rely on the industry to expect continued disruption, and in order to survive a chaotic landscape, they are advising businesses to spend money conservatively, work with trusted partners, and make comprehensive contingency plans.

Climate